Want to see AIP full AI Analyst Report?
Top Page
Arteris
(NASDAQ:AIP)
Select Model
Select Model
Rating:51Neutral
Price Target:
$23.00
▼(-0.99% Downside)
Action:Reiterated
Date:09/15/26
The score is held back primarily by persistent losses and inconsistent free cash flow alongside bearish technicals (price below major moving averages, negative MACD). Partially offsetting these are strong gross margins and a constructive earnings call with raised revenue guidance, record ACV/RPO, and an articulated path toward non-GAAP profitability.
Positive Factors
Revenue and demand growth
Strong recent revenue growth and higher full-year guidance indicate expanding adoption of Arteris interconnect IP across customer programs. If this momentum persists, greater design activity can increase license revenue and create a broader base for future royalty conversion.
Negative Factors
Persistent operating unprofitability
The company has not yet converted its strong gross margins into sustainable operating earnings, with substantial losses continuing on both reported and adjusted measures. Until revenue growth produces operating leverage, ongoing losses may constrain reinvestment flexibility and weaken the durability of its financial model.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue and demand growth
Strong recent revenue growth and higher full-year guidance indicate expanding adoption of Arteris interconnect IP across customer programs. If this momentum persists, greater design activity can increase license revenue and create a broader base for future royalty conversion.
Read all positive factors
Arteris Key Performance Indicators (KPIs)
Any
Annual Contract Value
Measures the total value of recurring contracts over a year, indicating the company's ability to secure long-term revenue streams and customer commitment.
Measures the total value of recurring contracts over a year, indicating the company's ability to secure long-term revenue streams and customer commitment.
Data provided by:
The Fly
The FlyArteris (AIP) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.10B
Dividend YieldN/A
Average Volume (3M)686.18K
Price to Earnings (P/E)―
Beta (1Y)1.85
Revenue Growth33.81%
EPS Growth-7.37%
CountryUS
Employees364
SectorTechnology
Sector Strength88
IndustrySemiconductors
Share Statistics
EPS (TTM)-0.87
Shares Outstanding49,152,103
10 Day Avg. Volume642,922
30 Day Avg. Volume686,183
Financial Highlights & Ratios
PEG Ratio4.06
Price to Book (P/B)-44.80
Price to Sales (P/S)9.29
P/FCF Ratio122.64
Enterprise Value/Market Cap1.98
Enterprise Value/Revenue25.81
Enterprise Value/Gross Profit29.72
Enterprise Value/Ebitda-58.33
Forecast
1Y Price Target
$39.43Price Target Upside69.73% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
EPS Forecast (FY)-0.18
Revenue Forecast (FY)$96.72M
Arteris Business Overview & Revenue Model
Company Description
Arteris, Inc., together with its subsidiaries, provides semiconductor system intellectual property (IP) solutions in the United States, rest of the Americas, China, Korea, the rest of the Asia Pacific, Europe, and the Middle East. It manages on-ch...
How the Company Makes Money
Arteris primarily makes money by licensing its semiconductor interconnect IP and providing related services and support to chip developers. Its revenue model typically includes: (1) License revenue: customers pay upfront fees to obtain the rights ...
Arteris Earnings Call Summary
Earnings Call Date:Aug 06, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Nov 10, 2026
Earnings Call Sentiment Positive
The call emphasized multiple record highs (ACV + royalties, royalties, RPO, revenue), strong top‑line growth (46% revenue YoY) and improving cash strength (positive FCF and $123M cash), alongside clear product and ecosystem momentum (Arm partnership, large FlexGen deals, diversified wins). Near‑term challenges include elevated payroll tax and commission driven OpEx, acquisition‑related charges, some royalty cadence variability, and continued GAAP losses. Management raised revenue guidance and reiterated a path to non‑GAAP profitability, while also disclosing one‑time and timing headwinds that modestly tempered profitability expectations.Positive Updates
Record ACV + Royalties
Exited Q2 2026 with ACV plus royalties of $99.5M, a 44% year‑over‑year increase and a new company record.
Negative Updates
Operating Losses and GAAP Drag
Non‑GAAP operating loss was $4.6M in Q2; GAAP operating loss was $13.9M and GAAP net loss was $14.1M (diluted loss per share $0.30). The company remains unprofitable on a GAAP basis.
Read all updates
Q2-2026 Updates
Positive
Negative
Record ACV + Royalties
Exited Q2 2026 with ACV plus royalties of $99.5M, a 44% year‑over‑year increase and a new company record.
Read all positive updates
Company Guidance
Management guided Q3 2026 to ACV plus royalties of $99M–$103M, revenue of $24M–$25M, and a non‑GAAP operating loss of $3M–$1M (noting this reflects a higher run‑rate of French employer payroll taxes on RSU vesting). For full‑year 2026 they raised revenue guidance to $95M–$98M (up $3.5M from prior guidance, ~37% YoY at the midpoint), expect ACV plus royalties to exit at $102M–$106M, project a non‑GAAP operating loss of $10M–$7M and non‑GAAP free cash flow of +$5M–+$9M (unchanged). They also reported RPO of $135M at quarter end with just over half expected to convert to revenue starting July 1, 2026, and reiterated that Arteris could reach non‑GAAP operating profitability as early as Q4 2026.Arteris Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
52
Neutral
Cash Flow
41
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 84.61M | 70.58M | 57.72M | 53.67M | 50.38M | 37.86M |
| Gross Profit | 73.48M | 63.68M | 51.76M | 48.59M | 46.10M | 34.13M |
| EBITDA | -37.44M | -29.70M | -24.83M | -28.52M | -25.33M | -20.27M |
| Net Income | -39.52M | -34.75M | -33.64M | -36.87M | -27.39M | -23.38M |
Balance Sheet | ||||||
| Total Assets | 224.71M | 115.03M | 106.14M | 102.80M | 115.52M | 120.44M |
| Cash, Cash Equivalents and Short-Term Investments | 122.06M | 54.60M | 43.84M | 41.17M | 68.15M | 85.83M |
| Total Debt | 8.69M | 9.08M | 5.99M | 7.75M | 3.62M | 3.91M |
| Total Liabilities | 157.04M | 129.66M | 107.32M | 87.70M | 77.98M | 67.54M |
| Stockholders Equity | 67.67M | -14.63M | -1.19M | 15.10M | 37.53M | 52.90M |
Cash Flow | ||||||
| Free Cash Flow | 6.77M | 5.34M | -1.04M | -17.23M | -7.82M | -1.62M |
| Operating Cash Flow | 8.51M | 6.73M | -720.00K | -15.73M | -6.77M | -814.00K |
| Investing Cash Flow | -4.98M | 12.03M | 970.00K | -4.69M | -37.48M | -1.36M |
| Financing Cash Flow | 73.60M | 1.42M | -262.00K | -2.92M | -4.15M | 76.25M |
Arteris Technical Analysis
Negative
23.23
Price Trends
24.46
Negative
30.46
Negative
24.79
Negative
Market Momentum
-0.23
Negative
42.39
Neutral
18.98
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AIP, the sentiment is Negative. The current price of 23.23 is above the 20-day moving average (MA) of 23.16, below the 50-day MA of 24.46, and below the 200-day MA of 24.79, indicating a bearish trend. The MACD of -0.23 indicates Negative momentum. The RSI at 42.39 is Neutral, neither overbought nor oversold. The STOCH value of 18.98 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AIP.
Arteris Risk Analysis
Arteris disclosed 67 risk factors in its most recent earnings report. Arteris reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Arteris Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $284.39B | 274.52 | 13.00% | ― | 25.12% | 48.03% | |
73 Outperform | $11.66B | 48.41 | 17.39% | ― | 17.17% | 3.84% | |
68 Neutral | $17.90B | 476.56 | 4.93% | ― | 33.25% | 15.45% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | $942.88M | -83.10 | -3.42% | ― | 8.82% | 2.60% | |
52 Neutral | $198.75M | -13.91 | -50.90% | ― | -9.42% | -61.14% | |
51 Neutral | $1.10B | -25.79 | -357.77% | ― | 33.81% | -7.37% |
* Technology Sector Average
AIP
Arteris
22.44
9.09
68.09%
CEVA
Ceva
33.49
4.62
16.00%
LSCC
Lattice Semiconductor
126.05
54.66
76.57%
QUIK
QuickLogic
10.85
4.20
63.16%
RMBS
Rambus
107.47
10.46
10.78%
ARM
ARM Holdings PLC ADR
266.28
94.34
54.87%
Arteris Corporate Events
Business Operations and StrategyExecutive/Board Changes
Arteris Appoints New Chief Financial Officer for Growth
Positive
Aug 6, 2026
On August 6, 2026, Arteris announced that it had appointed Saurabh Sinha as Chief Financial Officer, effective September 8, 2026, succeeding retiring CFO Nick Hawkins after his seven-year tenure. Hawkins, who helped lead Arteris through its IPO an...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.